Ongoing research is aimed at discovering more effective and safer neuroprotective agents. Advances in nanotechnology and gene therapy hold promise for delivering these agents directly to the brain. Additionally, a better understanding of the genetic and molecular basis of neurological diseases could lead to more targeted therapies.
